Skip to main content

Table 1 Characteristics of eligible studies considered in the report

From: Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer

Author

Sample type

Agea

Stages I%

Gender (M/F)

Patients (M+/M-)

Control (M+/M-)

Methods

Aim

Multiple target

Ad2Sc

Control design

Reference

Zhang et al. [27]b

Tissue

59

32.05

29/39

44/34

10/68

MSP

Diagnose

Yes

0.83

hom

[27]

Wang et al. [25]

Tissue

-

-

17/28

19/9

1/11

qMSP

Diagnose

Yes

2.14

heter

[25]

Jin et al. [15]

Tissue

66.7

-

17/24

27/45

22/41

qMSP

Non-diagnose

Yes

1.87

heter

[15]

Feng et al. [14]

Tissue

64.3

42.86

26/49

26/23

21/28

qMSP

Diagnose

Yes

1.43

hom

[14]

Brabender et al. [13]

Tissue

63.3

49.45

69/91

86/5

80/11

qMSP

Non-diagnose

Single

0.77

hom

[13]

Virmani et al. [24]

Tissue

-

-

-

22/26

0/18

MSP

Diagnose

Yes

NA

heter

[24]

Yanagawa et al. [26]

Tissue

67.3

66.67

18/25

28/47

36/39

MSP

Diagnose

Yes

1.48

hom

[26]

Topaloglu et al. [22]

Tissue

-

54.84

-

17/14

5/17

qMSP

Diagnose

Yes

3.00

heter

[22]

Kim et al. [16]

Tissue

63

56.57

64/79

48/41

33/66

MSP

Non-diagnose

Yes

0.62

hom

[16]

Vallbohmer et al. [23]

Tissue

63

49.45

69/91

86/5

80/3

PCR

Non-diagnose

Yes

0.77

hom

[23]

Lin et al. [17]

Tissue

61.1

100.00

20/31

49/75

2/24

MSP

Diagnose

Yes

1.84

heter

[17]

Shivapurkar et al. [20]

Tissue

-

-

-

35/5

23/17

qMSP

Diagnose

Yes

1.22

heter

[20]

Suzuki et al. [21]

Tissue

64

34.00

33/49

53/97

3/57

MSP

Non-diagnose

Yes

NA

heter

[21]

Zhang et al. [27]b

Serum

-

-

-

54/56

5/45

MSP

Diagnose

Yes

NA

heter

[27]

Pan et al. [18]

Serum

53

-

17/26

40/38

0/31

qMSP

Diagnose

Single

NA

heter

[18]

Begum et al. [12]

Serum

65

-

10/19

12/64

3/27

qMSP

Diagnose

Yes

NA

heter

[12]

Rykova et al. [19]

Serum

NA

-

-

3/6

0/16

MSP

Diagnose

Yes

NA

heter

[19]

Usadel et al. [10]

Serum

64.2

-

-

42/47

0/50

qMSP

Diagnose

Single

NA

heter

[10]

  1. amean or median age from articles; bwith two records since there are Tissue and serum data simultaneously in this article. M + and M- means methylation positive and methylation negative, respectively.
  2. Abbreviations: Ad2Sc, the ratio of adenocarcinoma to squamous cell carcinoma; hom, homogeneous control; heter, heterogeneous control. MSP, qualitative methylation detection method; qMSP, quantitative detection method; Sample type represents the samples analyzed.